Additional information
| Active substance | Valganciclovir Hydrochloride |
|---|---|
| Water Retention | Unlikely |
| Hepatotoxicity | Low risk but can occur |
| Lab Test | Monitoring of complete blood count and renal function tests are recommended |
| Strength | 450mg |
| Also known as | Valcyte |
| Blood pressure | No direct effects known |
| Trade name | Valcyte |
| Storage conditions | Store at room temperature between 15В°C and 30В°C (59В°F and 86В°F) |
| Chemical name | Valganciclovir hydrochloride |
| Formula | C14H22N6O5 |
| Substance class | Antiviral medication |
| Main action | Inhibits the replication of viral DNA |
| Half-life | 4 hours |
| Dosage (medical) | Typically 900 mg taken orally twice daily for induction therapy, and 900 mg once daily for maintenance therapy |
| Dosage (sports) | Not applicable |
| Effects | Reduction in viral load and improvement in symptoms associated with cytomegalovirus (CMV) infections |
| Side effects | Diarrhea, neutropenia, fever, anemia, leukopenia, and potential retinal detachment |
| Use in sports | None |
| Manufacturer | Cipla Ltd. |
| Packing | 4 tabs/blister |
Fostimon (Merional) 150 IU HMG IBSA
Norvacs 10 mg Pfizer
AVELOX 400 Bayer
Alpha Pharma Astralean 0,4 mcg 50 Tabletten
Balkan Pharma Anapolon 50 mg 60 Tabletten
Balkan Pharma Turanabol 10 mg 100 Tabletten
BIOSYNERGY RECOVERY3 PEPTIDE BLEND LIFETECH LABS
Norvacs 5 mg Pfizer
Champix 56 tabs Pfizer
Prograf 1mg Astellas Pharma
Balkan Pharma Oxandrolon 10 mg 60 Tabletten
Avory Pharma Dianabol 10mg 100 Kapsel
Roaccutane 20 Roche
LACIPIL 4 mg Glaxosmithkline 


Reviews
There are no reviews yet.